Antikoagulation bei Patienten mit chronischer Niereninsuffizienz: Empfehlungen der Arbeitsgemeinschaft "Herz-Niere" der Deutschen Gesellschaft für Kardiologie - Herz- und Kreislaufforschung und der Deutschen Gesellschaft für Nephrologie [Anticoagulation in patients with chronic kidney disease : Recommendations from the working group "Heart-Kidney" of the German Cardiac Society and the German Society of Nephrology]

Tools

Item Type:	Article
Title:	Antikoagulation bei Patienten mit chronischer Niereninsuffizienz: Empfehlungen der Arbeitsgemeinschaft "Herz-Niere" der Deutschen Gesellschaft für Kardiologie - Herz- und Kreislaufforschung und der Deutschen Gesellschaft für Nephrologie [Anticoagulation in patients with chronic kidney disease : Recommendations from the working group "Heart-Kidney" of the German Cardiac Society and the German Society of Nephrology]
Creators Name:	Schlieper, G., Schwenger, V., Remppis, A., Keller, T., Dechend, R., Massberg, S., Baldus, S., Weinreich, T., Hetzel, G., Floege, J., Mahfoud, F. and Fliser, D.
Abstract:	Indications for anticoagulation are thromboembolic events, prosthetic heart valves, and atrial fibrillation with a corresponding risk score. Clinical trials have excluded patients with advanced chronic kidney disease and these data cannot be always generalized to patients with chronic kidney disease. Non-vitamin K antagonist oral anticoagulants (NOACs) are mostly not recommended or are contraindicated in advanced stages of chronic kidney disease. Observational studies have shown that dialysis patients with atrial fibrillation do not profit from coumarin anticoagulants; prospective studies are lacking.
Keywords:	Atrial Fibrillation, Renal Disease, Anticoagulants, Phenprocoumon, Warfarin
Source:	Internist
ISSN:	0020-9554
Publisher:	Springer
Volume:	58
Number:	5
Page Range:	512-521
Date:	May 2017
Official Publication:	https://doi.org/10.1007/s00108-017-0220-5
PubMed:	View item in PubMed

Repository Staff Only: item control page